Biotech

All Articles

Praxis epilepsy medicine minimizes seizures in stage 2 trial

.Practice Precision Medicines has scored one more midphase succeed in epilepsy this year, with its s...

Three directors surrender as Dyne blog posts blended data for DMD prospect

.After leaving a clinical grip a number of years back, Dyne Rehab has actually uncovered new period ...

Arrowhead fires off phase 3 data in rare metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand before a potential showdown along with Ionis, rele...

Pfizer, Valneva show lyme disease try helpful for 2nd booster

.Pfizer and Valneva may possess regarding two more years to stand by prior to they make the initial ...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion along with Ayla Ellison, Strong Biotech Managing Editor and also Mic...

New information demonstrate how Bayer's asundexian neglected to avoid strokes

.Bayer suspended the stage 3 trial for its factor XIa inhibitor asundexian late in 2014 after the dr...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own various sclerosis (MS) med tolebrutinib to the FDA, execut...

Galapagos' stock up as fund shows intent to shape its own progression

.Galapagos is actually happening under additional pressure coming from capitalists. Having construct...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and retir...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has acquired on its own a starring role in China's KRAS market, pay...